Variable imprinting of H19 and IGF2 in fetal cerebellum and medulloblastoma

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 12, 1996, Pages 1270-1276

  Albrecht, Steffen ^a   Waha, Andreas ^c   Koch, Anke ^c   Kraus, Jürgen A ^c   Goodyer, Cynthia G ^b   Pietsch, Torsten ^c  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Genetic imprinting; H19 gene; Insulin like growth factor II gene; Loss of imprinting; Medulloblastoma

Indexed keywords

PROTEIN; SOMATOMEDIN B;

ADOLESCENT; ADULT; ARTICLE; CEREBELLUM; CHILD; CLINICAL ARTICLE; FEMALE; FETUS; GENE LOSS; GENOME IMPRINTING; HUMAN; HUMAN TISSUE; MALE; MEDULLOBLASTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 0029961227     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199612000-00011     Document Type: Article

References (52)

1. Feinberg AP. Genomic imprinting and gene activation in cancer. Nature Genet 1993;4:110-13
2. Efstratiadis A. Parental imprinting of autosomal mammalian genes. Curr Opin Genet Dev 1994;4:265-80
3. LeRoith D, Roberts CT. Insulin-like growth factors. Ann NY Acad Sci 1993;692:1-9
4. Thompson MA, Cox AJ, Whitehead RH, Jonas HA. Autocrine regulation of human tumor cell proliferation by insulin-like growth factor II: An in vitro model. Endocrinology 1990;126:3033-42
5. El-Badry O, Romanus JA, Helman LJ, Cooper MJ, Rechler MM, Israel MA. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J Clin Invest 1989;84: 829-39
6. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B. Tumour-suppressor activity of H19 RNA. Nature 1993;365:764-67
7. Moulton T, Crenshaw T, Hao Y, et al. Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nature Genet 1994;7:440-47
8. Pedone PV, Tirabosco R, Cavazzana AO, et al. Mono- and bi-allelic expression of insulin-like growth factor II gene in human muscle tumors. Hum Mol Genet 1994;3:1117-21
9. van Gurp RJHLM, Oosterhuis JW, Kalscheuer V, Mariman ECM, Looijenga LHJ. Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. J Natl Cancer Inst 1994;86: 1070-75
10. Vu TH, Yballe C, Boonyanit S, Hoffman AR. Insulin-like growth factor II in uterine smooth muscle tumors: Maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata. J Clin Endocrinol Metab 1995;80:1670-76
11. Suzuki H, Ueda R, Takahashi T, Takahashi T. Altered imprinting in lung cancer (letter). Nature Genet 1994;6:332-33
12. Ogawa O, Eccles MR, Szeto J, et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 1993;362:749-51
13. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP. Relaxation of imprinted genes in human cancer. Nature 1993;362:747-49
14. Rainier S, Dobry CJ, Feinberg AP. Transcribed dinucleotide repeat polymorphism in the IGF2 gene. Hum Mol Genet 1994;3:386
15. Steenman MJC, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nature Genet 1994;7:433-39
16. Taniguchi T, Sullivan MJ, Ogawa O, Reeve AE. Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc Natl Acad Sci USA 1995;92:2159-63
17. Ohlsson R, Hedborg F, Holmgren L, Walsh C, Ekström TJ. Over-lapping patterns of IGF2 and H19 expression during human development: Biallelic IGF2 expression correlates with lack of H19 expression. Development 1994;120:361-68
18. Hu JF, Vu TH, Hoffman AR. Differential biallelic activation of three insulin-like growth factor II promoters in the mouse central nervous system. Mol Endocrinol 1995;9:628-36
19. Munsick RA. Human fetal extremity lengths in the interval from 9 to 21 menstrual weeks of pregnancy. Am J Obstet Gynecol 1984;149:883-87
20. Pietsch T, Scharmann T, Fonatsch C, et al. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system. Cancer Res 1994;54:3278-87
21. Friedman HS, Burger PC, Bigner SH, et al. Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283 Med. J Neuropathol Exp Neurol 1985;44:592-605
22. Friedman HS, Burger PC, Bigner SH, et al. Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc. Am J Pathol 1988;130:472-84
23. Albrecht S, von Schweinitz D, Waha A, Kraus JA, von Deimling A, Pietsch T. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma. Cancer Res 1994;54:5041-44
24. Zhan S, Shapiro DN, Helman LJ. Activation of an imprinted allele of the insulin growth factor II gene implicated in rhabdomyosarcoma. J Clin Invest 1994;94:445-48
25. Zhang Y, Tycko B. Monoallelic expression of the human H19 gene. Nature Genet 1992;1:40-44
26. Bender B, Wiestler OD, von Deimling A. A device for processing large acrylamide gels. Biotechniques 1994;16:204-5
27. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. Am J Hum Genet 1991;48:137-44
28. Kalscheuer VM, Mariman EC, Schepens MT, Rehder H, Ropers HH. The insulin-like growth factor type-2 receptor gene is imprinted in the mouse but not in humans. Nature Genet 1993;5:74-78
29. Giannoukakis N, Deal C, Paquette J, Goodyer CG, Polychronakos C. Parental genomic imprinting of the human IGF2 gene. Nature Genet 1993;4:98-101
30. Davies SM. Developmental regulation of genomic imprinting of the IGF2 gene in human liver. Cancer Res 1994;54:2560-62
31. Zemel S, Bartolomei MS, Tilghman SM. Physical linkage of two mammalian imprinted genes, H19 and insulin-like growth factor 2. Nature Genet 1992;2:61-65
32. Leibovitch MP, Nguyen VC, Gross MS, Solhonne B, Leibovitch SA, Bernheim A. The human ASM (adult skeletal muscle) gene: Expression and chromosomal assignment to 11p15. Biochem Biophys Res Comm 1991;180:1241-50
33. Brannan CI, Dees EC, Ingram RS, Tilghman SM. The product of the H19 gene may function as an RNA. Mol Cell Biol 1990;10: 28-36
34. Zhang Y, Shields T, Crenshaw T, Hao Y, Moulton T, Tycko B. Imprinting of human H19: Allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching. Am J Hum Genet 1993;53:113-24
35. Brunkow ME, Tilghman SM. Ectopic expression of the H19 gene in mice causes prenatal lethality. Genes Dev 1991;5:1092-1101
36. Poirier F, Chan CTJ, Timmons PM, Robertson EJ, Evans MJ, Rigby PWJ. The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development 1991;113:1105-14
37. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM. Disruption of imprinting caused by deletion of the H19 region in mice. Nature 1995;375:34-39
38. Schroeder WT, Chao LY, Dao DD, et al. Nonrandom loss of maternal chromosome 11 alleles in Wilms tumors. Am J Hum Genet 1987;40:413-20
39. Pal N, Wadey RB, Buckle B, Yeomans E, Pritchard J, Cowell JK. Preferential loss of maternal alleles in sporadic Wilms' tumor. Oncogene 1990;5:1665-68
40. Scrable H, Cavenee W, Ghavimi F, Lovell M, Morgan K, Sapienza C. A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc Natl Acad Sci USA 1989;86: 7480-84
41. Kondo M, Suzuki H, Ueda R, et al. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene 1995;10:1193-98
42. Rainier S, Dobry CJ, Feinberg AP. Loss of imprinting in hepatoblastoma. Cancer Res 1995;55:1836-38
43. Montagna M, Menin C, Chieco-Bianchi L, D'Andrea E. Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma. J Cancer Res Clin Oncol 1994;120:732-36
44. Davies SM. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma. Cancer Res 1993;53:4781-83
45. Li X, Adam G, Cui H, Sandstedt B, Ohlsson R, Ekström TJ. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: Uncoupling of IGF2 and H19 imprinting. Oncogene 1995;11:221-29
46. Wada M, Seeger RC, Mizoguchi H, Koeffler HP. Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma. Cancer Res 1995;55:3386-88
47. Zhan S, Shapiro DN, Helman LJ. Loss of imprinting in Ewing's sarcoma. Oncogene 1995;11:2503-7
48. Pedone PV, Cosma MP, Ungaro P, et al. Parental imprinting of rat insulin-like growth factor II gene promoters is coordinately regulated. J Biol Chem 1994;269:23970-75
49. Tsang P, Gilles F, Yuan L, et al. A novel L-23 related gene 40 kb downstream of the imprinted H19 gene is biallelically expressed in mid-fetal and adult human tissues. Hum Mol Genet 1995;4:1499-1507
50. Bennett ST, Lucassen AM, Cough SCL, et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nature Genet 1995;9:284-92
51. Leighton PA, Saam JR, Ingram RS, Stewart CL, Tilghman SM. An enhancer deletion affects both H19 and Igf2 expression. Genes Dev 1995;9:2079-89
52. Ekström TJ, Cui H, Li X, Ohlsson R. Promoter-specific IGF2 imprinting status and its plasticity during human liver development. Development 1995;121:309-16